|
Match
|
Document |
Document Title |
|
|
6867217 |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
The invention relates to substituted polycyclic aryl and heteroaryl pyridone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods...
|
|
|
6861438 |
Antiviral agents
The invention provides a compound of formula I:
wherein G, R 2 , and R 3 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as...
|
|
|
6858734 |
Preparation of (S)-Clopidogrel and related compounds
A process for producing enantiomerically enriched (S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5 (4H)-acetic acid hydrocarbyl ester, represented by the formula:
Is provided,...
|
|
|
6852734 |
Indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
According to this invention, there is provided an indole derivative having the general formula (I)
wherein A is an oxygen atom or a nitrogen atom which nitrogen atom is optionally substituted...
|
|
|
6852731 |
Antiviral compounds
The invention provides a compound of formula I:
wherein G, R 2 , R 3 , and R 4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as...
|
|
|
6849620 |
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
The invention provides compounds of Formula I:
wherein Azabicyclo is
W 0 is a bicyclic moiety and is
These compounds may be in the form of pharmaceutical salts or...
|
|
|
6849622 |
Aliphatic nitrogenous five-membered ring compounds
The present invention is to provide an aliphatic nitrogen-containing 5-membered ring compound represented by the formula [I]:
wherein
A represents —CH 2 — or —S—, R 1 ...
|
|
|
6841559 |
Pyridinones to treat and prevent bacterial infections
Novel pyridinones and their derivatives which are effective in treating or preventing Gram-negative bacterial infections are provided. The pyridinones are stable and easily derivatized; the methods...
|
|
|
6833375 |
N-&lsqb 4-(heteroarylmethyl)phenyl&rsqb -heteroarylamines
The present invention is concerned with compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein R 1 is...
|
|
|
6833370 |
Heterocycle substituted aminoazacycles useful as central nervous system agents
Heterocyclic substituted aminoazacyclic compounds of formula I Z—R 3 I, wherein Z is a defined aminoazacycle and R 3 is a defined heterocycle moiety, pharmaceutical compositions of these...
|
|
|
6833456 |
Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use
The invention relates to compounds represented by the formula I and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein X, R 1 and R...
|
|
|
6831081 |
4-Oxo-4,7-dihydrothieno&lsqb 2,3-b&rsqb pyridine-5-carboxamides as antiviral agents
The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
|
|
|
6828330 |
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
The invention provides compounds of Formula I: wherein W 0 is a bicyclic moiety and is These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric...
|
|
|
6815440 |
Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acids
Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acids Compounds of the formula I are suitable for preparing pharmaceuticals for the treatment of disorders in the course...
|
|
|
6812247 |
Organometallic complex
A metal complex and its use for binding or cleaving a nucleic acid. The metal complex has the formula: M is Pt, Pd, Ni, Co, or Cu; X is aryl, heteroaryl, cyclyl, or heterocyclyl; Y is halogen,...
|
|
|
6809203 |
Oxazolo, thiazolo and selenazolo &lsqb 4,5-C&rsqb -quinolin-4-amines and analogs thereof
Thiazolo-, oxazolo- and selenazolo[4,5-c]quinolin-4-amines and analogs thereof are described including methods of manufacture and the use of novel intermediates. The compounds are immunomodulators...
|
|
|
6797710 |
Heterocyclic derivatives and their use as antithrombotic agents
The present invention relates to antithrombotic compounds comprising the group Q, Q having formula (I), wherein the substructure (i) is a structure selected from (a, b and c), wherein X is O or S;...
|
|
|
6797717 |
Anilide compounds and drugs containing the same
The invention relates to a novel anilide compound and a pharmaceutical composition comprising the same. The invention relates to a compound represented by the following general formula: ...
|
|
|
6780887 |
Anti-ischemic compounds
The present invention is related to a compound of formula (I), salts and pro-drugs of the compound (I) and methods for treating and/or preventing partial or total ischemia, methods for treating...
|
|
|
6770647 |
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
The present application describes to novel bicyclic hydroxamates derivatives of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, B, B 1 , B 2 , R 1 , and C are...
|
|
|
6767913 |
CRYSTAL FORMS III, IV, V, AND NOVEL AMORPHOUS FORM OF CLOPIDOGREL HYDROGENSULFATE, PROCESSES FOR THEIR PREPARATION, PROCESSES FOR THE PREPARATION OF FORM I, COMPOSITIONS CONTAINING THE NEW FORMS AND METHODS OF ADMINISTERING THE NEW FORMS
The present invention provides new crystalline Forms III, IV and V of clopidogrel hydrogensulfate and the amorphous form of clopidogrel hydrogensulfate, as well as their pharmaceutical...
|
|
|
6765011 |
7-heterocyclyl quinoline and thieno&lsqb 2,3-b&rsqb pyridine derivatives useful as antagonists of gonadotropin releasing hormone
The present invention is directed to novel 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives of the general formula (I) or (II) wherein all variables are as herein defined,...
|
|
|
6743793 |
Indole derivatives, process for preparation of the same and use thereof
Indole derivatives represented by formula (I): (wherein all symbols are described in the description), a process for the preparation of the same and a DP receptor antagonist comprising it as an...
|
|
|
6737411 |
Racemization and enantiomer separation of clopidogrel
Processes for separation of enantiomers of clopidogrel, and converting one enantiomer of clopidogrel to another enantiomer of clopidogrel are provided. The enantiomers are separated by...
|
|
|
6727258 |
Allosteric adenosine receptor modulators
The present invention relates to compounds of formula (IA): the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as allosteric adenosine receptor modulators...
|
|
|
6716841 |
Nitrogen containing heterobicycles as factor Xa inhibitors
This invention relates generally to nitrogen containing heterobicycles of formulas A and B: which are inhibitors of trypsin-like serine protease enzymes, especially factor Xa, pharmaceutical...
|
|
|
6713507 |
Ether compounds and compositions for cholesterol management and related uses
The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias,...
|
|
|
6703422 |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
The present invention relates to novel sulfide and disulfide compounds, compositions comprising sulfide and disulfide compounds, and methods useful for treating and preventing cardiovascular...
|
|
|
6693199 |
Method of making HIV protease inhibitors
A method of making HIV protease inhibitors of general formula (1): These HIV compounds inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV...
|
|
|
6693115 |
Acid addition salts of hydropyridine derivatives
Acid addition salts of 2-acetoxy-5-(α-cyclopropyl-carbonyl-2-fluorobenzyl)-4,5,6,7
-tetrahydrothieno[3,2-c]-pyridine. The acid addition salts of tetrahydrothienopyridine derivatives of the present...
|
|
|
6673780 |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
The present invention relates to novel sulfoxide and bis-sulfoxide compounds, compositions comprising sulfoxide and bis-sulfoxide compounds, and methods useful for treating and preventing...
|
|
|
6635763 |
Process to prepare clopidogrel
The present invention relates to a process for the preparation of thieno[3,2-c]pyridine derivatives having pharmacologically significant anti-aggregating and anti-thrombotic properties.
|
|
|
6620810 |
4-thioxo-4,7-dihydro-thieno&lsqb 2,3-b&rsqb pyridine-5-carboxamides as antiviral agents
The invention provides a compound of formula I: wherein R 1 , R 2 , R 3 , and R 4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as...
|
|
|
6613903 |
Modulators of protein tyrosine phosphatases (PTPases)
The present invention provides novel thienopyridines, novel compositions, methods of their use, and methods of their manufacture, where such compounds of Formula 1 are pharmacologically useful...
|
|
|
6596863 |
Medical composition containing nitroetheneamine Derivative or salt there of as active constituent
Process for producing a nitroetheneamine derivative or its stereoisomer, its tautomer or a salt thereof comprising reacting a compound of the formula with a compound of the formula R 6 —CH 2...
|
|
|
6534520 |
Antiviral compounds
The present invention relates to heterocyclic Compounds having antiviral activity. In particular, Compounds of formula (I): wherein B, W, X, Y, Q, R 1 , R 2 , R 3 , R 4 and n are as defined...
|
|
|
6525056 |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders
Corticotropin releasing factor (CRF) antagonists of Formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress...
|
|
|
6518281 |
Immunotherapeutic agents
Novel amides and imides are inhibitors of tumor necrosis factorα and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory...
|
|
|
6514988 |
Condensed-ring thiophene derivatives, their production and use
A gonadotropin-releasing hormone antagonistic composition, which comprises an optionally substituted condensed-bicyclic compound consisting of a homo or hetero 5 to 7 membered ring and a homo or...
|
|
|
6504030 |
Polymorphic form of clopidogrel hydrogen sulphate
Novel orthorombic polymorph of clopidogrel hydrogen sulfate or hydrogen sulfate of methyl (+)-(S)-α-(2-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]p
yridine-5-acetate and a process for its...
|
|
|
6498251 |
Tetrahydrobenzindole derivatives
Compounds containing tetrahydrobenzindole which bind to serotonin receptor and are useful in treatment or prevention of disease induced by abnormality of central peripheral serotonin controlling...
|
|
|
6495691 |
Process for the preparation of tetrahydrothieno&lsqb 3,2-c&rsqb pyridine derivatives
A process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives of general formula I: or their pharmaceutically acceptable salts, wherein the meaning of X is hydrogen, carboxyl,...
|
|
|
6492383 |
Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
The invention relates to compounds of the formulas 1 and 2 and to pharmaceutically acceptable salts and hydrates thereof, wherein X 1 , R 1 , R 2 and R 11 are as defined herein. The invention...
|
|
|
6486171 |
Piperidine compounds
A compound selected from those of formula (I): wherein: W represents optionally substituted naphthyl, or a group of formula Y (wherein) as defined in the description, n represents an integer...
|
|
|
6476022 |
Oxathiepino&lsqb 6,5-b&rsqb dihydropyridines, and related compositions and methods
This invention provides novel oxathiepino[6,5-b]dihydropyridines. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity....
|
|
|
6458950 |
Compounds and pharmaceutical compositions containing the same
A compound shown by the formula II, wherein Het is a mono- or polycyclic heterocyclic group comprising one or more hetero atoms selected from the group consisting of N, O and S which may be the...
|
|
|
6448261 |
Arylamino fused pyridines
Corticotropin releasing factor (CRF) antagonists of formula I; and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
|
|
|
6448262 |
Pesticidal and parasiticidal use of 2-(substituted thio) thiazolo-&lsqb 4,5-b&rsqb pyridine compounds
The present invention relates to the pesticidal and parasiticidal use of 2-(substituted thio)thiazolo[4,5-b]pyridine compounds having the structural formula I
|
|
|
6444617 |
Fused-heterocycle dicarboxylic acid diamide derivatives or salts thereof, herbicide and usage thereof
A fused heterocyclic dicarboxylic acid diamide derivative represented by formula (I): wherein R 1 is H, (C 1 -C 6 ) alkyl; R 2 and R 3 are H, (halo) (C 1 -C 6 ) alkyl, (C 3 -C 8 ) cycloalkyl,...
|
|
|
6437132 |
Thienopyridine derivatives, their intermediates and production thereof
The present invention provides an intermediate for producing a thienopyridine derivative useful as a GnRH antagonist as well as an efficient and safe method for producing the same in an industrial...
|